90 related articles for article (PubMed ID: 20056543)
21. In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton.
Hayot C; Farinelle S; De Decker R; Decaestecker C; Darro F; Kiss R; Van Damme M
Int J Oncol; 2002 Aug; 21(2):417-25. PubMed ID: 12118340
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic and antivascular 1-methyl-4-(3-fluoro-4-methoxyphenyl)-5-(halophenyl)-imidazoles.
Biersack B; Muthukumar Y; Schobert R; Sasse F
Bioorg Med Chem Lett; 2011 Nov; 21(21):6270-3. PubMed ID: 21963303
[TBL] [Abstract][Full Text] [Related]
23. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of aromatic enones related to curcumin.
Robinson TP; Hubbard RB; Ehlers TJ; Arbiser JL; Goldsmith DJ; Bowen JP
Bioorg Med Chem; 2005 Jun; 13(12):4007-13. PubMed ID: 15911313
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects.
Maffucci T; Piccolo E; Cumashi A; Iezzi M; Riley AM; Saiardi A; Godage HY; Rossi C; Broggini M; Iacobelli S; Potter BV; Innocenti P; Falasca M
Cancer Res; 2005 Sep; 65(18):8339-49. PubMed ID: 16166311
[TBL] [Abstract][Full Text] [Related]
26. Anti-angiogenic and anti-tumor apoptotic activities of a topoisomerase II inhibiting agent SJ-8026.
Yi EY; Jeong EJ; Kang DW; Joo JH; Kwon HS; Lee SH; Park SK; Chung SG; Cho EH; Kim YJ
Int J Oncol; 2005 Jun; 26(6):1613-20. PubMed ID: 15870877
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and antiangiogenic effects of a series of potent novel fumagillin analogues.
Lee HW; Cho CS; Kang SK; Yoo YS; Shin JS; Ahn SK
Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):1024-9. PubMed ID: 17603194
[TBL] [Abstract][Full Text] [Related]
28. A novel matrix metalloproteinase inhibitor, FYK-1388 suppresses tumor growth, metastasis and angiogenesis by human fibrosarcoma cell line.
Shinoda K; Shibuya M; Hibino S; Ono Y; Matsuda K; Takemura A; Zou D; Kokubo Y; Takechi A; Kudoh S
Int J Oncol; 2003 Feb; 22(2):281-8. PubMed ID: 12527923
[TBL] [Abstract][Full Text] [Related]
29. Juice of eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo.
Lirdprapamongkol K; Kramb JP; Chokchaichamnankit D; Srisomsap C; Surarit R; Sila-Asna M; Bunyaratvej A; Dannhardt G; Svasti J
In Vivo; 2008; 22(3):363-8. PubMed ID: 18610749
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of chelating agents as anti-angiogenic therapy through copper chelation.
Camphausen K; Sproull M; Tantama S; Venditto V; Sankineni S; Scott T; Brechbiel MW
Bioorg Med Chem; 2004 Oct; 12(19):5133-40. PubMed ID: 15351396
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of (3,4,5-trimethoxyphenyl)indol-3-ylmethane derivatives as potential antivascular agents.
Dupeyre G; Chabot GG; Thoret S; Cachet X; Seguin J; Guénard D; Tillequin F; Scherman D; Koch M; Michel S
Bioorg Med Chem; 2006 Jul; 14(13):4410-26. PubMed ID: 16529936
[TBL] [Abstract][Full Text] [Related]
32. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic sesquiterpenes from Aplysia dactylomela.
Dias T; Brito I; Moujir L; Paiz N; Darias J; Cueto M
J Nat Prod; 2005 Nov; 68(11):1677-9. PubMed ID: 16309323
[TBL] [Abstract][Full Text] [Related]
34. [Inhibitory effect of recombinant anti-angiogenic peptide of tumstatin on growth and metastasis of human ovarian cancer transplanted in nude mice].
Zhang GM; Sui LH; Jia T; Zhao YZ; Fu SB; Liu XH; Yu Y
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):170-3. PubMed ID: 18756929
[TBL] [Abstract][Full Text] [Related]
35. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
36. The antitumor effect of Tiazofurin (TR) consists of anti-proliferative and anti-invasive elements.
Tóvári J; Bocsi J; Ladányi A; Lapis K; Timár J
Anticancer Res; 1996; 16(6A):3307-12. PubMed ID: 9042305
[TBL] [Abstract][Full Text] [Related]
37. Halogenated helianane derivatives from the sponge Spirastrella hartmani.
Martín MJ; Berrué F; Amade P; Fernández R; Francesch A; Reyes F; Cuevas C
J Nat Prod; 2005 Oct; 68(10):1554-5. PubMed ID: 16252925
[TBL] [Abstract][Full Text] [Related]
38. Tridemethylisovelleral, a potent cytotoxic agent.
Aujard I; Röme D; Arzel E; Johansson M; de Vos D; Sterner O
Bioorg Med Chem; 2005 Nov; 13(22):6145-50. PubMed ID: 16055337
[TBL] [Abstract][Full Text] [Related]
39. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
[TBL] [Abstract][Full Text] [Related]
40. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
